These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29618008)

  • 1. Variable rescue of microtubule and physiological phenotypes in mdx muscle expressing different miniaturized dystrophins.
    Nelson DM; Lindsay A; Judge LM; Duan D; Chamberlain JS; Lowe DA; Ervasti JM
    Hum Mol Genet; 2018 Jun; 27(12):2090-2100. PubMed ID: 29618008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model.
    Rodino-Klapac LR; Janssen PM; Shontz KM; Canan B; Montgomery CL; Griffin D; Heller K; Schmelzer L; Handy C; Clark KR; Sahenk Z; Mendell JR; Kaspar BK
    Hum Mol Genet; 2013 Dec; 22(24):4929-37. PubMed ID: 23863459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid, redox-mediated mechanical susceptibility of the cortical microtubule lattice in skeletal muscle.
    Nelson DM; Fasbender EK; Jakubiak MC; Lindsay A; Lowe DA; Ervasti JM
    Redox Biol; 2020 Oct; 37():101730. PubMed ID: 33002761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.
    Harper SQ; Hauser MA; DelloRusso C; Duan D; Crawford RW; Phelps SF; Harper HA; Robinson AS; Engelhardt JF; Brooks SV; Chamberlain JS
    Nat Med; 2002 Mar; 8(3):253-61. PubMed ID: 11875496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle.
    Lindsay A; Larson AA; Verma M; Ervasti JM; Lowe DA
    J Appl Physiol (1985); 2019 Feb; 126(2):363-375. PubMed ID: 30571283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Truncated dystrophins reduce muscle stiffness in the extensor digitorum longus muscle of mdx mice.
    Hakim CH; Duan D
    J Appl Physiol (1985); 2013 Feb; 114(4):482-9. PubMed ID: 23221959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent variability of microtubule perturbations associated with dystrophinopathy.
    Belanto JJ; Olthoff JT; Mader TL; Chamberlain CM; Nelson DM; McCourt PM; Talsness DM; Gundersen GG; Lowe DA; Ervasti JM
    Hum Mol Genet; 2016 Nov; 25(22):4951-4961. PubMed ID: 28171583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle.
    Roberts ML; Wells DJ; Graham IR; Fabb SA; Hill VJ; Duisit G; Yuasa K; Takeda S; Cosset FL; Dickson G
    Hum Mol Genet; 2002 Jul; 11(15):1719-30. PubMed ID: 12095914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of human mini-dystrophin in transgenic mdx mice improves muscle physiological function.
    Chu X; Li J; Qiao C; Wang J; Wang Y; Jiang XC; You H; Xiao X; Wang B
    FASEB J; 2021 Jun; 35(6):e21628. PubMed ID: 33982338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle.
    Blaauw B; Mammucari C; Toniolo L; Agatea L; Abraham R; Sandri M; Reggiani C; Schiaffino S
    Hum Mol Genet; 2008 Dec; 17(23):3686-96. PubMed ID: 18753145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
    Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
    Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle.
    Roy P; Rau F; Ochala J; Messéant J; Fraysse B; Lainé J; Agbulut O; Butler-Browne G; Furling D; Ferry A
    Skelet Muscle; 2016; 6():23. PubMed ID: 27441081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy.
    Zhang Y; Yue Y; Li L; Hakim CH; Zhang K; Thomas GD; Duan D
    Hum Mol Genet; 2013 Sep; 22(18):3720-9. PubMed ID: 23681067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Implication of Hinge 1 and Hinge 4 in Micro-Dystrophin Gene Therapy for Duchenne Muscular Dystrophy.
    Wasala LP; Watkins TB; Wasala NB; Burke MJ; Yue Y; Lai Y; Yao G; Duan D
    Hum Gene Ther; 2023 May; 34(9-10):459-470. PubMed ID: 36310439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Split intein-mediated protein trans-splicing to express large dystrophins.
    Tasfaout H; Halbert CL; McMillen TS; Allen JM; Reyes TR; Flint GV; Grimm D; Hauschka SD; Regnier M; Chamberlain JS
    Nature; 2024 Aug; 632(8023):192-200. PubMed ID: 39020181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.
    Trajanovska S; Ban J; Huang J; Gregorevic P; Morsch M; Allen DG; Phillips WD
    J Physiol; 2019 Sep; 597(18):4831-4850. PubMed ID: 31340406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene.
    Sakamoto M; Yuasa K; Yoshimura M; Yokota T; Ikemoto T; Suzuki M; Dickson G; Miyagoe-Suzuki Y; Takeda S
    Biochem Biophys Res Commun; 2002 May; 293(4):1265-72. PubMed ID: 12054513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation.
    Ikezawa M; Cao B; Qu Z; Peng H; Xiao X; Pruchnic R; Kimura S; Miike T; Huard J
    Hum Gene Ther; 2003 Nov; 14(16):1535-46. PubMed ID: 14577915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.